Express Pharma - Page 175 of 2207 - Express Pharma

Lessons from the Delhi–Agra–Puducherry counterfeit medicine investigation

Immuneel and Arogya Finance launch India’s first zero cost EMI program for Qartemi CAR-T Cell Therapy

The fine line between reform and risk

Leadership evolution in India’s pharmaceutical sector in 2025- Driving global growth and innovation

Express Pharma March 2025

Cardiol’s CRD-38 holds potential to differentiate in HF space: GlobalData

Sionna Therapeutics’ NBD1 stabilisers hold potential to differentiate from Vertex’s existing therapies in cystic fibrosis: GlobalData

Zydus launches India’s first flu vaccine for southern hemisphere 2025 strain

Lupin included in S&P Global Sustainability Yearbook 2025 for the second consecutive year

Glenmark announces launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial

Motilal Oswal Alternates invests up to INR 460 crores for majority stake in Megafine

USFDA classifies inspection at Dr Reddy’s API facility as Voluntary Action Indicated

Nutraceuticals in preventive healthcare: Regulatory advancements and market growth highlighted at ASSOCHAM Summit